Vator Securities uppdragsanalys erbjuds till ett fåtal utvalda life science-bolag – ”By Invitation Only”.
Uppdragsanalyser publiceras löpande under 2019.
Commissioned research: AlzeCure Pharma
AlzeCure Pharma is a Swedish-based pharmaceutical company with potentially first-in-class proprietary and novel targeted small molecule (tablets) candidates for neurodegenerative diseases with a primary target on Alzheimer’s Disease (AD).
AlzeCure’s management team has extensive big pharma experience, and formed an integral part of AstraZeneca’s CNS department.